Completed NA INTERVENTIONAL 2-arm NCT01641120

Assessing Tolerability of Avonex Intramuscular Injections

Assessing Tolerability of Avonex Intramuscular Injections With a 25 Gauge Needle Versus 30 Gauge Needle

Sponsor: Biogen

Interventions Avonex

Updated 9 times since 2017 Last updated: Dec 18, 2015 Started: May 31, 2012 Primary completion: Feb 28, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Multiple Sclerosis and is currently completed. Biogen leads this study, which shows 9 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jul 2023 — Jul 2024 [monthly]

Completed NA
Jan 2023 — Jul 2023 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA

▶ Show 4 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biogen
Trinity Health Of New England

Data source: Trinity Health Of New England

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hartford, United States